40Indexed trials
mesh condition
Neurodegenerative Diseases
Intelligence
Neurodegenerative Diseases intelligence: 40 indexed trials, 12 recruiting studies, 37 sponsors across 44 countries.
12Recruiting
37Sponsors
44Countries
Leading sponsors
Novartis30 recruiting
Avid Radiopharmaceuticals20 recruiting
Beats Medical10 recruiting
Chinese University of Hong Kong10 recruiting
Eisai Co., Ltd.10 recruiting
Eisai Limited10 recruiting
Elizabeth K Rhodus10 recruiting
Eli Lilly and Company11 recruiting
Ente Ospedaliero Ospedali Galliera10 recruiting
Firalis SA10 recruiting
Fondazione Don Carlo Gnocchi ETS11 recruiting
Beijing Friendship Hospital10 recruiting
Geographic activity
United States14trials
France9trials
United Kingdom8trials
Italy7trials
Canada6trials
Germany6trials
South Korea4trials
Spain4trials
Netherlands4trials
Australia4trials
China4trials
Sweden3trials
Leading interventions
CAD1063trials
E20202trials
Auditory stimulation1trials
Digital Placebo Application1trials
Crenezumab1trials
Curcumin and ginkgo extract1trials
Deferiprone1trials
Dark chocolate (85% cocoa)1trials
Blood sampling, skin biopsy1trials
Donanemab1trials
Drug: [18F]florbetaben1trials
APO-Easy1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.